ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $65,000 | +3.2% | 44,702 | 0.0% | 0.00% | – |
| Q4 2016 | $63,000 | -14.9% | 44,702 | +5.6% | 0.00% | – |
| Q3 2016 | $74,000 | +2.8% | 42,345 | 0.0% | 0.00% | – |
| Q2 2016 | $72,000 | -13.3% | 42,345 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | +6.4% | 42,345 | +3.4% | 0.00% | – |
| Q4 2015 | $78,000 | 0.0% | 40,950 | 0.0% | 0.00% | – |
| Q3 2015 | $78,000 | -53.8% | 40,950 | +12.2% | 0.00% | – |
| Q2 2015 | $169,000 | -1.2% | 36,495 | -6.2% | 0.00% | – |
| Q1 2015 | $171,000 | +39.0% | 38,912 | +10.2% | 0.00% | – |
| Q4 2014 | $123,000 | -35.6% | 35,326 | -22.6% | 0.00% | – |
| Q3 2014 | $191,000 | -28.7% | 45,658 | 0.0% | 0.00% | – |
| Q2 2014 | $268,000 | -39.9% | 45,658 | -35.5% | 0.00% | -100.0% |
| Q1 2014 | $446,000 | +26.3% | 70,753 | +17.3% | 0.00% | 0.0% |
| Q4 2013 | $353,000 | -6.4% | 60,330 | -15.6% | 0.00% | 0.0% |
| Q3 2013 | $377,000 | -17.3% | 71,459 | +20.6% | 0.00% | 0.0% |
| Q2 2013 | $456,000 | – | 59,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |